AstraZeneca COVID drug neutralizes Omicron sub-variants in study

The therapy, Evusheld, was tested against the BA.1, BA.1.1, and BA.2 subvariants of Omicron and it was also shown to limit inflammation in the lungs

from mint - Science https://ift.tt/3HtahFj
https://ift.tt/AHrKkx7